Form 4 filed by Keller Eric L.
Keller Eric L. filed this Form 4 on Retension Pharmaceuticals, Inc. with 6 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-13 22:12:28 UTC.
- Accession
- 0001213900-26-109160
- Filer
- CIK 2156365
- Filed
- 2026-10-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: Retension Pharmaceuticals, Inc. (CIK 2002988)
- Keller Eric L. director, officer (CHIEF EXECUTIVE OFFICER)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-13 | P bought | +20,800 | $12 | 423,377 | D |
| Common Stock | 2026-10-13 | C converted | +9,662 | 433,039 | D | |
| Common Stock | 2026-10-13 | C converted | +31,368 | 464,407 | D | |
| Stock Option (right to buy) derivative | 2026-10-13 | A granted | +255,174 | $0 | 255,174 | D |
| Series A Convertible Preferred Stock derivative | 2026-10-13 | C converted | -9,662 | 0 | D | |
| Series B Convertible Preferred Stock derivative | 2026-10-13 | C converted | -31,368 | 0 | D |